Translational Medicine @ UniSa
Volume 24

Issue 1

Article 3

January 2021

The Time for a Consensus Regarding the Coeliac Disease
Diagnosis in Adults has come: Balancing the Pros and Cons of
Omitting the Biopsy
Carolina Ciacci
University of Salerno

Julio C. Bao
Dr. C. BonorinoUdaondo Gastroenterology Hospital. Buenos Aires, Argentina. Research Institute,
Universidad del Salvador. Buenos Aires, Argentina

Follow this and additional works at: https://tmj.unisa.it/journal
Part of the Health Communication Commons, Life Sciences Commons, and the Medicine and Health
Sciences Commons

Recommended Citation
Ciacci, Carolina and Bao, Julio C. (2021) "The Time for a Consensus Regarding the Coeliac Disease
Diagnosis in Adults has come: Balancing the Pros and Cons of Omitting the Biopsy," Translational
Medicine @ UniSa: Vol. 24 : Iss. 1 , Article 3.
Available at: https://doi.org/10.37825/2239-9747.1027

This Letter to the Editor is brought to you for free and open access by Translational Medicine @ UniSa. It has been
accepted for inclusion in Translational Medicine @ UniSa by an authorized editor of Translational Medicine @
UniSa.

LETTER TO THE EDITOR

The Time for a Consensus Regarding the Coeliac
Disease Diagnosis in Adults has come: Balancing the
Pros and Cons of Omitting the Biopsy
Carolina Ciacci a,*, Julio C. Bao b,c
a

Department of Medicine, Surgery, Dentistry, Scuola Medica Salernitana, Italy
Dr. C. Bonorino Udaondo Gastroenterology Hospital, Buenos Aires, Italy
c
Research Institute, Universidad del Salvador, Buenos Aires, Italy
b

Abstract
How balancing the pros and cons of omitting the biopsy in diagnosing CeD in adults?
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To the Editor,

C

oeliac disease (CeD) is an immunomediated
chronic disease that develops in genetically
susceptible individuals after consuming gluten-containing cereals. The epidemiology of CeD reveals that
it is a common food intolerance, affecting about 1% of
the global population with a few exceptions [1]. The
blood levels of IgA type anti-tissue transglutaminase
(tTG) antibodies and the histology of perendoscopic
intestinal biopsies showing mucosal damage are
considered the “gold standard” to make the diagnosis
[2]. Since its introduction in the mid-1950s, duodenal
biopsy has been essential [3,4]. Upper GI endoscopy
became the preferred method for obtaining duodenal
biopsies in the 1980s [5]. A seminal study published in
1996 investigated, for the ﬁrst time, the possibility of
diagnosing CeD in adults solely based on speciﬁc
serology (anti-endomysial: 100% positive predictive
value and 70% sensitivity) [6]. As a result, several
studies with a similar goal of investigating adult and
children patients were conducted. Based on all of the
previous studies, the ESPGHAN established in 2012
that high levels of tTG IgA (x10) accurately predicted
the presence of atrophic intestinal mucosa in symptomatic patients. Further ESPGHAN-funded
research conﬁrmed that the serological strategy could

replace biopsy in children, even in asymptomatic
cases [7]. As a result, a new ESPGHAN consensus
conﬁrmed that in children omitting the biopsy in the
presence of a high anti-tTG IgA titer is a safe and
recommended practice in diagnosing CeD [7].
There is an exciting debate among CeD experts
about the possibility of omitting the biopsyin adults
when the titer of anti-tTGis high. The topic reasonably divides the CeD experts for several reasons.
First, a diagnosis of CeD is forever. The idea of
conﬁrming by histology the serology ﬁndings is
reassuring. However, the same is for children and
adults, and for children, the no-biopsy strategy is
now the standard of care.
Secondly, there is a reasonable worry to miss the
diagnosis of diseases other than CeD. In the suspicion of CeD for digestive symptoms or iron deﬁciency, the upper endoscopy might unveil other
diseases such as peptic ulcer and gastric cancer, besides obtaining the intestinal biopsy. However, data
from the literature are reassuring as in a multicenter
study, coincident signiﬁcant UGI endoscopic ﬁndings appear to be rare in adult CeD [8].
Another con toward the biopsy is that CeD is
considered a precancerous disease, and adults may
receive a late diagnosis of CeD. The long-time gluten
exposure and the presence of symptoms increase the
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frequency of the most alarming complication of
CeD, the intestinal T-cell lymphoma [9].
Nevertheless, lymphoma diagnosis is relatively
infrequent at the endoscopy, although the diagnosis
of lymphoma and CeD might be almost simultaneous [10].
Finally, the histology allows the diagnosis of potential CeD, i.e., positive anti tTG Ig A and absence of
mucosa damage. The potential CeD remains a
problem to solve as a non-neglectable percentage of
potential CeD patients may never develop mucosal
damage [11].
Which are the pros of omitting the biopsy?
Indeed, the presence of high titer anti-tTG IgA in
adults shows the same accuracy as in children in
predicting intestinal mucosa atrophy. Endoscopy is
an unpleasant and expensive procedure. Histology
is often operator-dependent; it also resents good
sampling and orientations of the specimen.
The question now is to balance the pros and cons
of omitting the biopsy in diagnosing CeD in adults.
The right time has come to put together all the
scientiﬁc evidence and ask a group of experts to
reach a consensus on the issue. The consensus
would possibly select the appropriate condition(s)
for which the omission of the endoscopy would be
safe regarding missing other diseases and granting
accuracy for the diagnosis of CeD.
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